Re-weighting the Model for End-Stage Liver Disease Score Components

Gastroenterology

Volumn 135, Issue 5, 2008, Pages 1575-1581

  Sharma, Pratima ^a   Schaubel, Douglas E ^b,c   Sima, Camelia S ^c,d   Merion, Robert M ^a,c   Lok, Anna S F ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Scientific Registry of Transplant Recipients   (United States)

^d ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; ETHNICITY; FEMALE; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REGISTRATION; SCORING SYSTEM;

EID: 55249103360     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.08.004     Document Type: Article

References (17)

1. Wiesner R., Edwards E., Freeman R., et al. Model for End-Stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology 124 (2003) 91-96
2. Malinchoc M., Kamath P.S., Gordon F.D., et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31 (2000) 864-871
3. Huo T.I., Wu J.C., Lin H.C., et al. Evaluation of the increase in Model for End-Stage Liver Disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. J Hepatol 42 (2005) 826-832
4. Heuman D.M., and Mihas A. Utility of the MELD score for assessing 3-month survival in patients with liver cirrhosis: one more positive answer. Gastroenterology 125 (2003) 992-995
5. Wiesner R.H., Edwards E., and Kamath P. Mayo End-Stage Liver Disease (MELD) model predicts liver transplant waiting list mortality: implications for liver allocation policy. Transplantation 71 (2001) 461
6. Kim W., Kremers W., Malinchoc M., et al. Determinant of death on liver transplant waiting list: waiting time, blood group or MELD?. Hepatology 34 (2001) 204A
7. Merion R.M., Rush S.H., Dykstra D.M., et al. Predicted lifetimes for adult and pediatric split liver versus adult whole liver transplant recipients. Am J Transplant 4 (2004) 1792-1797
8. Gonwa T.A., McBride M.A., Anderson K., et al. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us?. Am J Transplant 6 (2006) 2651-2659
9. Pomfret E.A., Fryer J.P., Sima C.S., et al. Liver and intestine transplantation in the United States, 1996-2005. Am J Transplant 7 Suppl 1 (2007) 1376-1389
10. Kalbfleisch J.D., and Prentice R.L. The statistical analysis of failure time data (2002), Wiley, New York
11. Allison P.D. Survival analysis using SAS: a practical guide (1995), SAS Institute, Cary, NC
12. Harrell Jr. F.E., Lee K.L., and Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15 (1996) 361-387
13. Schemper M., and Stare J. Explained variation in survival analysis. Stat Med 15 (1996) 1999-2012
14. Organ procurement and transplant network-HRSA. Final rule with comment period. Anonymous. Federal Register 63 (1998) 16296-16338
15. Brown R.S., Rush S.H., Rosen H.R., et al. Liver and intestine transplantation. Am J Transplant 4 Suppl 9 (2004) 81-92
16. Nair S., Verma S., and Thuluvath P.J. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 35 (2002) 1179-1185
17. Narayanan Menon K.V., Nyberg S.L., Harmsen W.S., et al. MELD and other factors associated with survival after liver transplantation. Am J Transplant 4 (2004) 819-825